McKesson Corp (MCK)
703.76
-5.73 (-0.81%)
NYSE · Last Trade: Aug 6th, 9:32 PM EDT
Detailed Quote
Previous Close | 709.49 |
---|---|
Open | 703.02 |
Bid | 685.00 |
Ask | 697.00 |
Day's Range | 687.20 - 711.48 |
52 Week Range | 464.42 - 737.89 |
Volume | 1,305,564 |
Market Cap | 108.85B |
PE Ratio (TTM) | 27.34 |
EPS (TTM) | 25.7 |
Dividend & Yield | 2.840 (0.40%) |
1 Month Average Volume | 667,633 |
Chart
About McKesson Corp (MCK)
McKesson Corporation is a leading healthcare services and information technology company that specializes in the distribution of pharmaceuticals and medical supplies. The company provides a comprehensive range of services that enhance the efficiency of healthcare systems, including drug distribution to pharmacies, hospitals, and other healthcare providers. Additionally, McKesson offers innovative solutions for managing medical costs, optimizing inventory, and improving patient care through data analytics and technology. By ensuring the timely delivery of critical medical products and services, McKesson plays a vital role in the healthcare ecosystem, supporting both providers and patients. Read More
News & Press Releases
Healthcare distributor and services company McKesson (NYSE:MCK) announced better-than-expected revenue in Q2 CY2025, with sales up 23.4% year on year to $97.83 billion. Its non-GAAP profit of $8.26 per share was 1.4% above analysts’ consensus estimates.
Via StockStory · August 6, 2025
Check out these five stocks that are beating the market in 2025 and just announced dividend increases of between 10% and 15%.
Via MarketBeat · August 6, 2025
McKesson Corp (NYSE:MCK) beat Q1 2026 revenue and EPS estimates, raising full-year guidance. Stock dipped slightly post-earnings amid high expectations.
Via Chartmill · August 6, 2025
McKesson Corporation (NYSE: MCK) has released its fiscal 2026 first quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.
By McKesson Corporation · Via Business Wire · August 6, 2025
Synergy CHC Corp. (NASDAQ: SNYR), the consumer health powerhouse behind the FOCUSfactor® brand, is making headlines again as its CEO took to the airwaves to spotlight the company’s 25-year journey from brain-boosting tablets to energy drinks and weight management innovation.
Via AB Newswire · August 6, 2025
U.S. stocks rebounded sharply on Wednesday, fully erasing last Friday's losses, as upbeat corporate earnings and renewed investor optimism outweighed concerns over escalating trade tensions.
Via Benzinga · August 6, 2025
Healthcare distributor and services company McKesson (NYSE:MCK)
will be reporting results this Wednesday after market close. Here’s what investors should know.
Via StockStory · August 4, 2025
Via Benzinga · August 1, 2025
The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of $0.82 per share of common stock, a 15% increase from $0.71 per share in the prior quarter. The dividend will be payable on October 1, 2025, to stockholders of record on September 2, 2025.
By McKesson Corporation · Via Business Wire · July 30, 2025
McKesson Corp (MCK) shows strong growth fundamentals and a promising technical breakout setup, making it a potential growth stock pick with upside potential.
Via Chartmill · July 25, 2025
Growth is oxygen.
But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.
Via StockStory · July 21, 2025
Via Benzinga · July 18, 2025
Momentum in medical and tech-focused small caps continues to explode, led by
Via AB Newswire · July 15, 2025
MCKESSON CORP (NYSE:MCK) offers strong growth in healthcare distribution with reasonable valuation and solid financial health, making it a candidate for growth-at-a-price investors.
Via Chartmill · July 15, 2025
Synergy CHC Corp. (NASDAQ: SNYR) is capturing national attention with the announcement of a strategic distribution partnership with McKesson Canada, a division of McKesson Corporation (NYSE: MCK) . The agreement gives FOCUSfactor® direct access to thousands of pharmacies and health-focused retailers across Canada, igniting the next phase of its aggressive North American expansion.
Via AB Newswire · July 14, 2025
MCKESSON CORP (NYSE:MCK) shows strong growth fundamentals and a bullish technical setup, making it a stock to watch. The company's solid financials and breakout potential suggest further upside.
Via Chartmill · July 4, 2025
The spice maker said it is implementing several initiatives to manage the higher costs from tariffs.
Via Stocktwits · June 27, 2025
Via Benzinga · June 26, 2025
McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2026 financial results after market close on Wednesday, August 6, 2025. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
By McKesson Corporation · Via Business Wire · June 26, 2025
MCKESSON CORP (NYSE:MCK) meets Minervini’s Trend Template with strong technicals and high growth fundamentals, making it a stock to watch for momentum investors.
Via Chartmill · June 16, 2025